DIREXION DAILY S&P BIOTECH BULL 3X SHARES - ETF (LABU) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2016 to Q3 2025

Type / Class
Equity / ETF
Symbol
LABU
Price per share
$94.01
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
2,983
Total reported value
$312,596
% of total 13F portfolios
0%
Share change
+1,842
Value change
+$205,140
Number of holders
4
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 4 institutional investors reported holding 2,983 shares of DIREXION DAILY S&P BIOTECH BULL 3X SHARES - ETF (LABU).

Institutional Holders of DIREXION DAILY S&P BIOTECH BULL 3X SHARES - ETF (LABU) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 2,983 $312,596 +$205,140 $94.01 4
2025 Q2 1,141 $65,191 +$12,048 $57.02 4
2025 Q1 3,419 $208,183 +$104,684 $60.97 5
2024 Q4 1,702 $153,395 +$53,191 $90.00 5
2024 Q3 1,111 $142,933 -$61,535 $128.74 4
2024 Q2 1,589 $180,134 +$59,329 $113.42 4
2024 Q1 1,066 $140,528 -$485,200 $132.72 3
2023 Q4 4,980 $607,410 -$21,230,830 $121.97 5
2023 Q3 4,927,275 $18,773,368 +$167,633 $3.81 46
2023 Q2 4,588,110 $27,148,747 +$3,022,728 $5.92 47
2023 Q1 4,080,000 $20,032,779 -$18,220,429 $4.91 53
2022 Q4 6,982,845 $49,379,959 +$16,233,038 $7.07 46
2022 Q3 4,714,072 $33,044,103 +$6,478,001 $7.01 44
2022 Q2 3,820,225 $25,744,955 +$7,190,033 $6.74 42
2022 Q1 2,161,971 $33,920,567 +$13,769,566 $15.67 28
2021 Q4 1,173,749 $42,380,000 +$13,311,605 $36.00 32
2021 Q3 472,395 $26,110,000 +$3,277,283 $55.30 28
2021 Q2 345,616 $25,476,000 -$8,473,706 $73.65 24
2021 Q1 453,242 $35,549,000 +$12,790,023 $78.91 28
2020 Q4 248,950 $25,001,000 -$7,113,315 $100.43 18
2020 Q3 341,847 $18,416,355 -$2,311,877 $53.55 20
2020 Q2 378,378 $22,480,000 -$13,503,162 $59.42 20
2020 Q1 705,492 $15,912,000 -$51,137 $22.54 19
2019 Q4 708,416 $40,731,000 +$6,466,504 $57.50 22
2019 Q3 723,425 $22,207,000 -$7,897,060 $30.90 20
2019 Q2 817,504 $41,106,000 +$1,264,696 $50.19 27
2019 Q1 782,293 $46,812,000 -$2,089,172 $59.88 23
2018 Q4 798,418 $26,210,000 +$8,404,125 $32.86 28
2018 Q3 21,889 $2,034,000 -$5,055,669 $76.92 5
2018 Q2 244,297 $23,209,000 -$6,501,807 $94.94 14
2018 Q1 309,876 $24,605,000 -$5,528,952 $79.41 13
2017 Q4 382,192 $29,766,000 -$14,364,016 $77.85 19
2017 Q3 565,253 $48,278,000 +$9,254,858 $85.47 18
2017 Q2 463,931 $29,308,000 +$868,068 $63.05 18
2017 Q1 255,819 $12,226,000 +$4,678,771 $47.72 16
2016 Q4 400,756 $12,904,000 +$1,628,857 $31.30 13
2016 Q3 241,882 $7,463,000 -$6,702,771 $33.55 5
2016 Q2 864,154 $24,459,000 +$12,633,422 $28.22 18
2016 Q1 417,248 $11,438,200 +$10,852,200 $27.42 20